Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pain, Postoperative × Therapeutics × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 46 Fatigue 14 Neoplasms 9 Prostatic Neoplasms 7 Depression 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Lymphoma, Non-Hodgkin 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Hodgkin Disease 6 Carcinoma, Ovarian Epithelial 6 Testicular Neoplasms 5 Lymphoma, Mantle-Cell 5 Lymphoma, Large-Cell, Immunoblastic 5 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, Follicular 5 Lymphoma, B-Cell, Marginal Zone 5 Leukemia, Myeloid, Chronic-Phase 5 Leukemia, Myeloid, Acute 5 Leukemia, Myeloid, Accelerated Phase 5 Leukemia, Hairy Cell 5 Burkitt Lymphoma 5 Blast Crisis 5 Primary Myelofibrosis 4 Pain 4 Neuroblastoma 4 Multiple Myeloma 4 Lymphoma, T-Cell, Cutaneous 4 Lung Neoplasms 4 Leukemia, Myelomonocytic, Chronic 4 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4

Interventions

Bupivacaine 8 Control Groups 6 Saline Solution 5 Ketamine 5 Sodium Chloride 4 Ropivacaine 4 Lidocaine 4 Dexmedetomidine 4 Anesthetics, Local 4 Morphine 3 Anti-Inflammatory Agents, Non-Steroidal 3 Diazepam 2 Botulinum Toxins, Type A 2 Analgesics, Opioid 2 Acetaminophen 2 thiamine triphosphorate 1 oxycodone-acetaminophen 1 esmolol 1 Vitamins 1 Tramadol 1 Therapeutics 1 Surgical Procedures, Operative 1 Sufentanil 1 Nerve Block 1 Narcotics 1 Nalbuphine 1 Mindfulness 1 Mastectomy, Segmental 1 Mammaplasty 1 Magnesium Sulfate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04518085 2023-12-08

PREVENT

University of Oslo

Phase NA Completed

Data powered by HemOnc (CC BY 4.0) Colophon ⚡